PSAT1 PSAT1 inhibitor for enhancing radiation sensitivity and combination use thereof

The present invention provides a PSAT1 inhibitor for enhancing radiation sensitivity, and a combination use of the PSAT1 inhibitor and CB-839. A composition of the present invention exhibits excellent cancer prevention or treatment activity through the combination use of two active components, and t...

Full description

Saved in:
Bibliographic Details
Main Authors PARK IN CHUL, HONG SUNG EUN, JIN HYEON OK
Format Patent
LanguageEnglish
Korean
Published 31.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides a PSAT1 inhibitor for enhancing radiation sensitivity, and a combination use of the PSAT1 inhibitor and CB-839. A composition of the present invention exhibits excellent cancer prevention or treatment activity through the combination use of two active components, and the PSAT1 inhibitor alone can enhance the radiation sensitivity of cancer. Accordingly, by using the composition of the present invention, it is possible to overcome radiation resistance while providing cancer treatment, and to reduce the incidence of complications caused by radiation treatment. 본 발명은 방사선 민감성 증진용 PSAT1 억제제와 PSAT1 억제제 및 CB-839 의 병용 용도를 제공한다. 본 발명의 조성물은 두 유효 성분의 병용을 통해 우수한 암의 예방 또는 치료 활성을 나타내며, PSAT1 억제제는 단독으로서도 암의 방사선 민감도를 증진시킬 수 있다. 이에 따라, 본 발명의 조성물을 이용하여 암 치료 뿐만 아니라 방사선 저항성을 극복하고, 방사선 치료에 의한 합병증 발병을 감소시킬 수 있다.
AbstractList The present invention provides a PSAT1 inhibitor for enhancing radiation sensitivity, and a combination use of the PSAT1 inhibitor and CB-839. A composition of the present invention exhibits excellent cancer prevention or treatment activity through the combination use of two active components, and the PSAT1 inhibitor alone can enhance the radiation sensitivity of cancer. Accordingly, by using the composition of the present invention, it is possible to overcome radiation resistance while providing cancer treatment, and to reduce the incidence of complications caused by radiation treatment. 본 발명은 방사선 민감성 증진용 PSAT1 억제제와 PSAT1 억제제 및 CB-839 의 병용 용도를 제공한다. 본 발명의 조성물은 두 유효 성분의 병용을 통해 우수한 암의 예방 또는 치료 활성을 나타내며, PSAT1 억제제는 단독으로서도 암의 방사선 민감도를 증진시킬 수 있다. 이에 따라, 본 발명의 조성물을 이용하여 암 치료 뿐만 아니라 방사선 저항성을 극복하고, 방사선 치료에 의한 합병증 발병을 감소시킬 수 있다.
Author PARK IN CHUL
HONG SUNG EUN
JIN HYEON OK
Author_xml – fullname: PARK IN CHUL
– fullname: HONG SUNG EUN
– fullname: JIN HYEON OK
BookMark eNqNissKwjAQRbPQha9_GHAtNBGK2yKK4Ea0rkuaTsyATkoyCv69Qv0AF_ecxblTNeLIOFHX06WqNQwkDtSSxAT-O-Rg2RHfINmOrFBkyMiZhF4kb7DcgYuPlnhoz4wgARNGP1djb-8ZFz_P1HK_q7eHFfaxwdxbh4zSHM-mMLooSqM3ZbX-7_UBcX47IA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 방사선 민감성 증진용 PSAT1 억제제 및 이의 병용 용도
ExternalDocumentID KR20210062186A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20210062186A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:38:43 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20210062186A3
Notes Application Number: KR20190150080
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210531&DB=EPODOC&CC=KR&NR=20210062186A
ParticipantIDs epo_espacenet_KR20210062186A
PublicationCentury 2000
PublicationDate 20210531
PublicationDateYYYYMMDD 2021-05-31
PublicationDate_xml – month: 05
  year: 2021
  text: 20210531
  day: 31
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
RelatedCompanies_xml – name: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
Score 3.2905529
Snippet The present invention provides a PSAT1 inhibitor for enhancing radiation sensitivity, and a combination use of the PSAT1 inhibitor and CB-839. A composition of...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PSAT1 PSAT1 inhibitor for enhancing radiation sensitivity and combination use thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210531&DB=EPODOC&locale=&CC=KR&NR=20210062186A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsQAdepJmmqQLmmQCTTOm6CZaJhnrJhuADjMzME1KBl8G4-tn5hFq4hVhGsHEkAPbCwM-J7QcfDgiMEclA_N7Cbi8LkAMYrmA11YW6ydlAoXy7d1CbF3UoL1jYP8FmKbUXJxsXQP8Xfyd1Zydbb2D1PyCIHIGZqAbmByZGViBDWlzUH5wDXMC7UspQK5U3AQZ2AKA5uWVCDEwZecLM3A6w-5eE2bg8IVOeQOZ0NxXLMIQGhDsGGKoACEz8zIyk4DZsUgB2OxUSM3LAB2ckZeuUAQ6bADkAYVi0Np0yOUQCol5KQpADwK7wRC50uJUBVDTLzU_TZRB2c01xNlDF-i-eHhwxHsHIXvGWIyBJS8_L1WCQSEN3H1KMjVINEoD5kvzRMuUJGNjYAPI1NwkERghkgwy-EySwi8tzcAF4kJmzmUYWEqKSlNlgRVySZIcOBwBVmqNng
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRofVTfRcCOilD4OxLTQBu0zlZreGrYFSzRLU2j8-84sVHvqhRAm2ewsfLszzO73ATzUiPQkMLhKRSYqM85Vr851daYRmZlm8JkUg-n1K864_DYxJjn43pyFkTyhP5IcERE1Q7wncr5e_v_EsuXeyviRh_goemm7pq1k2THmL_hNKXbTbA0H9sBSLMvsjJT-KLVpFVJgauzBPgbZNdI7aH006VzKcntRaR_DwRDbE8kJ5L6iIhSsjfZaEQ57WckbbzP0xacwHr433CeWXkOxCDnCccUw7GS-WBBxhvhkKyIbIAdYTHvTU3EI5ok5QwcxDU5t69hnFPr5UXAG9-2Wazkq9m_6NxzTzmjbGf0c8iIS_gWwQKZP3NC85wBxWfXqc67rGAAZ1bKHL-QSSrtautptvoOC4_a60-5rv3MNR2RKq-glyCertX-Di3PCb-WY_gIjWZCO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PSAT1+PSAT1+inhibitor+for+enhancing+radiation+sensitivity+and+combination+use+thereof&rft.inventor=PARK+IN+CHUL&rft.inventor=HONG+SUNG+EUN&rft.inventor=JIN+HYEON+OK&rft.date=2021-05-31&rft.externalDBID=A&rft.externalDocID=KR20210062186A